These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 30315413)
1. The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth? Ayhan A; Akilli H; Haberal N Arch Gynecol Obstet; 2019 Jan; 299(1):217-222. PubMed ID: 30315413 [TBL] [Abstract][Full Text] [Related]
2. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Ayhan A; Mao TL; Seckin T; Wu CH; Guan B; Ogawa H; Futagami M; Mizukami H; Yokoyama Y; Kurman RJ; Shih IeM Int J Gynecol Cancer; 2012 Oct; 22(8):1310-5. PubMed ID: 22976498 [TBL] [Abstract][Full Text] [Related]
3. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type. Cuff J; Longacre TA Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820 [TBL] [Abstract][Full Text] [Related]
4. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis. Paik ES; Kim TJ; Choi CH; Kim BG; Bae DS; Lee JW J Gynecol Oncol; 2018 Mar; 29(2):e18. PubMed ID: 29400011 [TBL] [Abstract][Full Text] [Related]
6. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma. Soovares P; Pasanen A; Bützow R; Lassus H Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395 [TBL] [Abstract][Full Text] [Related]
7. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma. Ju UC; Kang WD; Kim SM Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis. Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411 [TBL] [Abstract][Full Text] [Related]
10. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis. Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Scarfone G; Bergamini A; Noli S; Villa A; Cipriani S; Taccagni G; Vigano' P; Candiani M; Parazzini F; Mangili G Gynecol Oncol; 2014 Jun; 133(3):480-4. PubMed ID: 24642093 [TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Davis M; Rauh-Hain JA; Andrade C; Boruta DM; Schorge JO; Horowitz NS; May T; del Carmen MG Gynecol Oncol; 2014 Mar; 132(3):760-6. PubMed ID: 24440832 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer]. Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019 [No Abstract] [Full Text] [Related]
14. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Sainz de la Cuesta R; Eichhorn JH; Rice LW; Fuller AF; Nikrui N; Goff BA Gynecol Oncol; 1996 Feb; 60(2):238-44. PubMed ID: 8631545 [TBL] [Abstract][Full Text] [Related]
15. Endometriosis-Associated Ovarian Cancer: Population Characteristics and Prognosis. Barreta A; Sarian L; Ferracini AC; Eloy L; Brito ABC; de Angelo Andrade L; Derchain S Int J Gynecol Cancer; 2018 Sep; 28(7):1251-1257. PubMed ID: 30142123 [TBL] [Abstract][Full Text] [Related]
16. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis. Chew S; Tham KF; Ratnam SS Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094 [TBL] [Abstract][Full Text] [Related]
17. Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma. Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH Int J Gynecol Cancer; 2018 Jan; 28(1):11-18. PubMed ID: 28930811 [TBL] [Abstract][Full Text] [Related]
18. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles. Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593 [TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of the PTEN protein and matrix metalloproteinase-2 in endometrial cysts, endometrioid and clear cell ovarian cancer. Brucka A; Szyłło K Ginekol Pol; 2013 May; 84(5):344-51. PubMed ID: 23819399 [TBL] [Abstract][Full Text] [Related]
20. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas. Zhan X; Li L; Wu M; Lang J Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]